30 patents
Page 2 of 2
Utility
Compositions and Methods for Safe Treatment of Rhinitis
4 Nov 20
Methods for treating rhinitis in a subject are provided herein.
Curtis L. Ruegg, Hongran Fan Stone, Jacob M. Waugh
Filed: 10 Feb 19
Utility
Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
2 Sep 20
Methods and systems for chromatographically purifying a botulinum neurotoxin are provided.
Curtis L. RUEGG
Filed: 1 Dec 19
Utility
Compositions and methods for topical application and transdermal delivery of botulinum toxins
17 Aug 20
Improved formulations for transdermal delivery of botulinum toxin are disclosed.
Michael D Dake, Jacob M Waugh
Filed: 23 Sep 18
Utility
CorrectedTopical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
15 Jul 20
A composition of botulinum toxin is claimed which can penetrate into the ocular surface inclusive of a penetration through a conjunctiva, cornea, and other structures.
Gary E. Borodic
Filed: 25 Feb 18
Utility
Injectable Botulinum Toxin Formulations
8 Jul 20
This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes.
Curtis L. Ruegg, Hongran Fan Stone, Jacob M. Waugh
Filed: 16 Oct 19
Utility
Methods of Treatment for Cervical Dystonia
10 Jun 20
This invention provides methods to treat or prevent cervical dystonia, a disorder related thereto, or a symptom thereof, with novel injectable compositions comprising botulinum toxin that may be administered to a subject suffering from such maledy.
Curtis L. Ruegg, Jacob M. Waugh
Filed: 17 May 18
Utility
Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
1 Apr 20
Compositions and methods are provided that are useful for the delivery, including transdermal delivery, of biologically active agents, such as non-protein non-nucleotide therapeutics and protein-based therapeutics excluding insulin, botulinum toxins, antibody fragments, and VEGF.
Michael D. Dake, Jacob M. Waugh
Filed: 6 Jan 19
Utility
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
11 Mar 20
The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety and sleep disorders and CNS disorders comprising the administration of a neurotoxin.
Gary E. Borodic
Filed: 11 Nov 19
Utility
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
18 Dec 19
The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety and sleep disorders and CNS disorders comprising the administration of a neurotoxin.
Gary E. Borodic
Filed: 13 Jan 19
Utility
Botulinum toxin and the treatment of primary disorders of mood and affect
14 Oct 19
A method of treating circadian rhythm disorders includes identifying a subject with a circadian rhythm disorder or at least one symptom of a circadian rhythm disorder and administering an effective amount of a composition comprising a botulinum toxin and a pharmaceutically acceptable carrier to said subject thereby reducing at least one symptom of a circadian rhythm disorder.
Gary E. Borodic
Filed: 13 Sep 15